[CLDX] QoQ Quarter Result on 30-Jun-2021 [#Q2]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
05-Aug-2021
Financial Year
2021
Quarter
30-Jun-2021 [#Q2]
Profit Trend
QoQ- 19.14%
YoY- -21.23%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Quarter Result
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
Revenue 174 333 153 3,480 685 3,786 668 -59.24%
PBT -23,050 -20,148 -20,679 -13,373 -16,538 -22,839 -14,224 38.00%
Tax -1,486 -874 -227 382 764 -939 1,088 -
NP -21,564 -20,148 -20,452 -13,373 -16,538 -21,900 -14,224 32.00%
Tax Rate - - - - - - - -
Total Cost 21,738 20,481 20,605 16,853 17,223 25,686 14,892 28.70%
Ratio Analysis
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
NP Margin -12,393.10 -6,050.45 -13,367.32 -384.28 -2,414.31 -578.45 -2,129.34 223.90%
Per Share
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
EPS -0.46 -0.43 -0.45 -0.34 -0.42 -0.55 -0.36 17.77%
EPS Diluted -0.46 -0.43 -0.45 -0.34 -0.42 -0.55 -0.36 17.77%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.